Spectranetics' Extreme 0.9mm catheter gains PMA supplement:
This article was originally published in Clinica
Spectranetics has obtained FDA approval for its application to market the Extreme 0.9mm disposable catheter for laser coronary angioplasty. The catheter is designed to remove blockages in small coronary vessels that are hard to reach. The company of Colorado Springs, Colorado, plans only a limited release of the product in the two months before a full launch in October.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.